Form 8K Sera Prognostics Inc For: 19 August
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Sera Prognostics Inc (SERA)
Sera Prognostics Inc stock price live, this page displays NASDAQ SERA stock exchange data. View the SERA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Sera Prognostics Inc real time stock price chart below.
What Is the Sera Prognostics Inc Stock Price Today?
The Sera Prognostics Inc stock price today is 2.03.
What Is the Stock Symbol for Sera Prognostics Inc?
The stock symbol for Sera Prognostics Inc is "SERA."
What Stock Exchange Does Sera Prognostics Inc Trade On?
Sera Prognostics Inc is listed and trades on the NASDAQ stock exchange.
Is Sera Prognostics Inc a Good Stock to Buy?
Determining whether Sera Prognostics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SERA quote. (ISIN: US81749D1072)
What Is the Sera Prognostics Inc Stock Price Today?
The Sera Prognostics Inc stock price today is 2.03.
What Is the Stock Symbol for Sera Prognostics Inc?
The stock symbol for Sera Prognostics Inc is "SERA."
What Stock Exchange Does Sera Prognostics Inc Trade On?
Sera Prognostics Inc is listed and trades on the NASDAQ stock exchange.
Is Sera Prognostics Inc a Good Stock to Buy?
Determining whether Sera Prognostics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SERA quote. (ISIN: US81749D1072)
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.98
2.20
52 wk Range
1.56
3.95
SERA is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.982.20
52 wk Range
1.563.95
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
SERA Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
5.50
Upside
+170.94%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
Form 4 Sera Prognostics Inc For: 14 July- Investing.com
Form 4 Sera Prognostics Inc For: 14 July- Investing.com
- Form 8K Sera Prognostics Inc For: 19 August
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 5.50
(+170.94% Upside)
Sera Prognostics Inc Earnings Call Summary for Q2/2026
- Sera Prognostics posted Q2 2026 revenue of $30,000, up 76.5% YoY but missing estimates by 53%; adjusted loss of $0.18/share vs. $0.15 expected.
- Company ended quarter with $80.3M cash, sufficient to fund operations through 2029; net loss widened to $9.1M from $8.0M year-earlier.
- Illinois Medicaid coverage expected to yield 1-2% penetration of 50,000 eligible pregnancies in 2027, rising to 5% by 2029 as adoption scales.
- Management said PRIME study shifted business from validation to adoption phase; testing volumes rising steadily post-publication.
- CE mark application for European market planned for Q4 2026 after additional ELISA testing to address sample stability and reduce execution risk.
Last Updated: 2026/08/12, 23:56
Read Full TranscriptEarnings
Latest Release
Aug 12, 2026
EPS / Forecast
-0,18 / -0,15
Revenue / Forecast
30K / 63,88K
Compare SERA to Peers and Sector
Metrics to compare | SERA | Sector Sector - Average of metrics from a broad group of related Industrials sector companies | Relationship RelationshipSERAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.4x | −1.9x | −0.4x | |
PEG Ratio | −0.13 | 0.02 | 0.00 | |
Price/Book | 1.3x | 0.5x | 2.6x | |
Price / LTM Sales | 1,144.0x | 19.1x | 3.1x | |
Upside (Analyst Target) | 163.2% | 159.2% | 47.0% | |
Fair Value Upside | Unlock | 9.3% | 5.6% | Unlock |
Sera Prognostics, Inc., a women’s health company, discovers, develops, and commercializes blood-based biomarker tests, and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation. It is also involved in the development of a pipeline of novel blood-based biomarker tests and predictive analytic products and services for pregnancy related conditions, such as time-to-birth, predictive analytics product, pregnancy risk prediction panel, preeclampsia, and fetal growth restriction. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Sera Prognostics (SERA) Stock Price Today?
The Sera Prognostics stock price today is 2,03 USD.
What Stock Exchange Does Sera Prognostics Trade On?
Sera Prognostics is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Sera Prognostics?
The stock symbol for Sera Prognostics is "SERA."
What Is the Sera Prognostics Market Cap?
As of today, Sera Prognostics market cap is 80,08M USD.
What Is Sera Prognostics's Earnings Per Share (TTM)?
The Sera Prognostics EPS (TTM) is -0,66.
When Is the Next Sera Prognostics Earnings Date?
Sera Prognostics will release its next earnings report on Nov 11, 2026.
From a Technical Analysis Perspective, Is SERA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Sera Prognostics Stock Split?
Sera Prognostics has split 0 times.
How Many Employees Does Sera Prognostics Have?
Sera Prognostics has 72 employees.
What is the current trading status of Sera Prognostics (SERA)?
As of Aug 28, 2026, Sera Prognostics (SERA) is trading at a price of 2,03 USD, with a previous close of 2,09 USD. The stock has fluctuated within a day range of 1,98 USD to 2,20 USD, while its 52-week range spans from 1,56 USD to 3,95 USD.
What Is Sera Prognostics (SERA) Price Target According to Analysts?
The average 12-month price target for Sera Prognostics is 5,50 USD, with a high estimate of 6 USD and a low estimate of 5 USD. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +170,94% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.